Generation, characterization and uses thereof of anti-Her 3 antibodies

Details for Australian Patent Application No. 2010303443 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Zhang, Ningyan; Huber, Hans

Agent Spruson & Ferguson

Pub. Number AU-A-2010303443

PCT Pub. Number WO2011/044311

Priority 61/250,060 09.10.09 US

Filing date 7 October 2010

Wipo publication date 14 April 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/044311 Priority application(s): WO2011/044311

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010303445-Crusher device

2010303441-Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity